Abstract
Colloidal stability is among the key challenges the pharmaceutical industry faces during production and manufacturing of protein therapeutics. Self-association and aggregation processes can not only impair therapeutic efficacy but also induce immunogenic responses in patients. Aggregation-prone regions (APRs) consisting of hydrophobic patches are commonly identified as the source for colloidal instability and rational strategies to mitigate aggregation propensity often require genetic engineering to eliminate hydrophobic amino acid residues. Here, we investigate cucurbit[7]uril (CB[7]), a water soluble macrocycle able to form host-guest complexes with aromatic amino acid residues, as a potential excipient to mitigate protein aggregation propensity. Two monoclonal antibodies (mAbs), one harbouring an APR and one lacking an APR, were first assessed for their colloidal stability (measured as the translational diffusion coefficient) in the presence and absence of CB[7] using dynamic light scattering (DLS). Due to the presence of a tryptophan residue within the APR, we were able to monitor changes in intrinsic fluorescence in response to increasing concentrations of CB[7]. Isothermal titration calorimetry (ITC) and NMR spectroscopy were then used to characterize the putative host-guest interaction. Our results suggest a stabilizing effect of CB[7] on the aggregation-prone mAb, due to the specific interaction of CB[7] with aromatic amino acid residues located within the APR. This provides a starting point for exploring CB[7] as a candidate excipient for the formulation of aggregation prone mAbs.
| Original language | English |
|---|---|
| Journal | Molecular Pharmaceutics |
| Early online date | 15 May 2019 |
| DOIs | |
| Publication status | Published - 2019 |
Fingerprint
Dive into the research topics of 'Interaction of a macrocycle with an aggregation-prone region of a monoclonal antibody'. Together they form a unique fingerprint.Equipment
-
Biomolecular NMR Facility
Cliff, M. (Core Facility Lead)
Manchester Institute of BiotechnologyFacility/equipment: Facility